相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prostate tumors downregulate microseminoprotein-beta (MSMB) in the surrounding benign prostate epithelium and this response is associated with tumor aggressiveness
Sofia Halin Bergstrom et al.
PROSTATE (2018)
Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer
Brandon A. Mahal et al.
EUROPEAN UROLOGY (2018)
The Proteome of Prostate Cancer Bone Metastasis Reveals Heterogeneity with Prognostic Implications
Diego Iglesias-Gato et al.
CLINICAL CANCER RESEARCH (2018)
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
M. J. Duffy et al.
EUROPEAN JOURNAL OF CANCER (2017)
Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response
Erik Bovinder Ylitalo et al.
EUROPEAN UROLOGY (2017)
Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy
Shuang G. Zhao et al.
JAMA ONCOLOGY (2017)
Aggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis
Kerstin Stromvall et al.
PLOS ONE (2017)
A Systems Approach to Prostate Cancer Classification-Letter
Elin Thysell et al.
CANCER RESEARCH (2017)
The Stromal Niche for Epithelial Stem Cells: A Template for Regeneration and a Brake on Malignancy
Kelsey J. Roberts et al.
CANCER CELL (2017)
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome
Miriam Ragle Aure et al.
BREAST CANCER RESEARCH (2017)
Molecular Profiles of Prostate Cancer: To Treat or Not to Treat
Itay A. Sternberg et al.
ANNUAL REVIEW OF MEDICINE, VOL 67 (2016)
Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome
Sungyong You et al.
CANCER RESEARCH (2016)
High Caveolin-1 Expression in Tumor Stroma Is Associated with a Favourable Outcome in Prostate Cancer Patients Managed by Watchful Waiting
Peter Hammarsten et al.
PLOS ONE (2016)
Secreted Factors from Colorectal and Prostate Cancer Cells Skew the Immune Response in Opposite Directions
Marie Lundholm et al.
SCIENTIFIC REPORTS (2015)
Adaptive (TINT) Changes in the Tumor Bearing Organ Are Related to Prostate Tumor Size and Aggressiveness
Hanibal Hani Adamo et al.
PLOS ONE (2015)
TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers
Christina Hagglof et al.
PLOS ONE (2014)
ErbB2 Receptor Immunoreactivity in Prostate Cancer: Relationship to the Androgen Receptor, Disease Severity at Diagnosis and Disease Outcome
Peter Hammarsten et al.
PLOS ONE (2014)
Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort
G. Fisher et al.
BRITISH JOURNAL OF CANCER (2013)
The reactive stroma microenvironment and prostate cancer progression
David A. Barron et al.
ENDOCRINE-RELATED CANCER (2012)
Phospho-Akt Immunoreactivity in Prostate Cancer: Relationship to Disease Severity and Outcome, Ki67 and Phosphorylated EGFR Expression
Peter Hammarsten et al.
PLOS ONE (2012)
Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance
Andreas Josefsson et al.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2012)
The Stroma—A Key Regulator in Prostate Function and Malignancy
Christina Hägglöf et al.
Cancers (2012)
Prostate Cancer Increases Hyaluronan in Surrounding Nonmalignant Stroma, and This Response Is Associated with Tumor Growth and an Unfavorable Outcome
Andreas Josefsson et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: implications for pathological practice
Geert J. L. H. van Leenders et al.
MODERN PATHOLOGY (2011)
Mast Cells Are Novel Independent Prognostic Markers in Prostate Cancer and Represent a Target for Therapy
Anna Johansson et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Low Levels of Phosphorylated Epidermal Growth Factor Receptor in Nonmalignant and Malignant Prostate Tissue Predict Favorable Outcome in Prostate Cancer Patients
Peter Hammarsten et al.
CLINICAL CANCER RESEARCH (2010)
Nuclear androgen receptor staining in bone metastases is related to a poor outcome in prostate cancer patients
S. Crnalic et al.
ENDOCRINE-RELATED CANCER (2010)
Stromal PDGFRβ Expression in Prostate Tumors and Non-Malignant Prostate Tissue Predicts Prostate Cancer Survival
Christina Hagglof et al.
PLOS ONE (2010)
Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study
D. M. Berney et al.
BRITISH JOURNAL OF CANCER (2009)
Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer
Tobias Zellweger et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Low Stroma Androgen Receptor Level in Normal and Tumor Prostate Tissue Is Related to Poor Outcome in Prostate Cancer Patients
Pernilla Wikstrom et al.
PROSTATE (2009)
Tumor size, vascular density and proliferation as prognostic markers in GS 6 and GS 7 prostate tumors in patients with long follow-up and non-curative treatment
A Josefsson et al.
EUROPEAN UROLOGY (2005)
Prognostic value of the Gleason score in prostate cancer
L Egevad et al.
BJU INTERNATIONAL (2002)
分享论文
